Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding

M. Alderman, K. Arakawa, L. Beilin, J. Chalmers, J. Cohn, R. Collins, R. R. Fenichel, E. D. Frohlich, P. Hamet, L. Hansson, C. Hennekens, E. Kuschnir, L. Lisheng, S. MacMahon, G. Mancia, I. Martin, J. Menard, P. Sleight, J. Whitworth, S. YusufA. Zanchetti, B. Neal

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)61-72
Number of pages12
JournalHypertension Research
Volume20
Issue number2
Publication statusPublished - 1997

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Alderman, M., Arakawa, K., Beilin, L., Chalmers, J., Cohn, J., Collins, R., Fenichel, R. R., Frohlich, E. D., Hamet, P., Hansson, L., Hennekens, C., Kuschnir, E., Lisheng, L., MacMahon, S., Mancia, G., Martin, I., Menard, J., Sleight, P., Whitworth, J., ... Neal, B. (1997). Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Hypertension Research, 20(2), 61-72.